This weekly report provides a current epidemiological update on the intensity and severity of respiratory activity in Manitoba including laboratory confirmed activity of both COVID-19 and seasonal influenza. Surveillance data include syndromic indicators, laboratory testing, associated hospitalization and mortality, and outbreaks. Updates around immunization coverage in COVID-19 and seasonal influenza are also included.
Data are reported with a one-week delay for increased data accuracy, completeness and reliability. More analyses continue to be conducted and will be added to this report as available. It is published online at approximately 10:00am every Friday.
Data extracted up to 1:00 am on September 21, 2023
Next reporting
date: September 29, 2023
Outbreak reporting is currently under review and will resume mid October.
|
|
|||||||||||||
|
|
|||||||||||||
|
||||||||||||||
|
|
|
||||||||||||
|
||||||||||||||
|
|
|
||||||||||||
Important Notes
|
Figure 1. Weekly Cases of COVID-19 by Season, Manitoba, 2020 – 2024 (July through June)
Figure 2. Sex and Age Distribution of COVID-19 Cases, Manitoba, July 2, 2023 – September 16, 2023
Figure 3. Cases of COVID-19 by Health Region and Public Health Report Date, Manitoba, July 2, 2023 – September 16, 2023
Figure 4. Average Daily Testing Volume and Positivity (%) for COVID-19 by Week of Specimen Receiving Date, Manitoba, July 2, 2023 – September 16, 2023
Figure 5. Severe Outcomes of COVID-19 by Week of Outcome Date, Manitoba, July 2, 2023 – September 16, 2023
Note. ICU admissions are not included in the hospital admissions.
Table 1. Coverage of COVID-19 Vaccinations, Manitoba, September 16, 2023
Age group (years) | At least 1 dose | At least 2 doses | At least 1 dose within the last 6 months | At least 1 dose of Bivalent |
---|---|---|---|---|
.5-04 | 10.1% | 6.5% | 2.3% | 0.1% |
05-11 | 50.2% | 38.6% | 1.1% | 2.2% |
12-17 | 80.7% | 74.8% | 0.6% | 7.6% |
18-29 | 86.5% | 83.5% | 0.5% | 8.4% |
30-39 | 83.2% | 80.7% | 0.6% | 13.5% |
40-49 | 87.8% | 85.9% | 0.8% | 18.6% |
50-59 | 85.4% | 84.1% | 1.5% | 24.6% |
60-69 | >=95.0% | 94.1% | 5.0% | 44.8% |
70-79 | 102% | 101% | 12.4% | 63.1% |
80+ | >=95.0% | >=95.0% | 17.8% | 65.3% |
ALL | 80.4% | 77.2% | 2.9% | 21.8% |
For more information, please visit COVID-19 vaccination coverage in Canada - Canada.ca
Figure 6. Weekly Cases of Influenza by Season, Manitoba, 2019 – 2024 (July through June)
Figure 7. Average Daily Testing Volume and Positivity (%) for Influenza by Week of Specimen Receiving Date, Manitoba, July 2, 2023 – September 16, 2023
Figure 8. Number of Positive Respiratory Virus Tests by Week of Specimen Receiving Date, Manitoba, July 2, 2023 – September 16, 2023
Note. Other respiratory viruses include adenovirus, enterovirus/rhinovirus, human coronavirus (seasonal), human metapneumovirus and human parainfluenza virus.
BackTable 2. Coverage of Influenza Vaccinations, Manitoba, September 1, 2022 – September 16, 2023
Age group | Doses | Coverage percentage |
---|---|---|
0-4 | 17464 | 20.7% |
5-17 | 37440 | 16.1% |
18-49 | 96701 | 15.9% |
50-64 | 83349 | 32.1% |
65+ | 146561 | 60.3% |
All | 387796 | 27.2% |
Figure 9. Weekly FluWatchers Participants and Percentage Reporting Fever and Cough, Manitoba, 2019 – September 16, 2023
Figure 10. Weekly Percentage of ILI Related Visits to Sentinel Physicians, Manitoba, 2018 – September 16, 2023
Figure 11. Weekly Units of Antiviral Dispensed from Pharmacies, Manitoba, 2018 – September 16, 2023
Figure 12. Weekly Respiratory Visits to Emergency Department, Manitoba, 2017 – September 16, 2023